Back to Events

5th Annual Gene Therapy for Rare Disorders congress

  • Start Date: Monday, 7 March 2022
Location: Boston, MA

The ​5th Annual Gene Therapy for Rare Disorders congress returns to Boston on March 7-10, 2022.

As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, Gene Therapy for Rare Disorders 2022 will provide in-depth insights from experts who know how to drive clinical progress, optimize manufacturing, and demonstrate the value of gene therapy products to regulators, payers, and patients.

Key insights will be shared from pioneering companies and institutions in the space, including Novartis Gene Therapies, Spark Therapeutics, bluebird bio, Orchard Therapeutics, AskBio, Ultragenyx, AVROBIO, ARM, Dyno Therapeutics, FDA, Freeline Therapeutics and several more. This meeting is your opportunity to leverage their knowledge and deliver value to your entire gene therapy team.